Pharmacological approaches to the management of pain in the neonatal intensive care unit

Journal of Perinatology

Volumn 27, Issue , 2007, Pages S4-S11

  Anand, K J S ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Agitation; Analgesia; Infant newborn; Infant premature; Pain; Stress

Indexed keywords

CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; FENTANYL; GABAPENTIN; KETAMINE; LOCAL ANESTHETIC AGENT; MEMANTINE; METHADONE; METOCLOPRAMIDE; MEXILETINE; MIDAZOLAM; MORPHINE; NALOXONE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; OXYBUTYNIN; PHENYTOIN; PLACEBO; STEROID; TETRACAINE;

AGITATION; AMNESIA; ANALGESIA; ARTICLE; BRADYCARDIA; BRAIN BLOOD FLOW; BRAIN NERVE CELL; BRONCHOSPASM; CLINICAL PRACTICE; CLINICAL TRIAL; CONTINUOUS INFUSION; DIAGNOSTIC TEST; DISTRESS SYNDROME; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG HALF LIFE; DRUG METABOLISM; DRUG TOLERANCE; HUMAN; HYPOTENSION; INDIVIDUALIZATION; INTENSIVE CARE; LOADING DRUG DOSE; LOW DRUG DOSE; NEUROPATHIC PAIN; NEWBORN; NEWBORN CARE; PAIN; PAIN ASSESSMENT; PHYSICIAN; PREMATURITY; RESPIRATION DEPRESSION; SEDATION; SEIZURE; SIDE EFFECT; SOMATOSENSORY CORTEX; TRANQUILIZING ACTIVITY; VISCERAL PAIN;

ANALGESICS; ANALGESICS, OPIOID; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INTENSIVE CARE UNITS, NEONATAL; KETAMINE; MALE; METHADONE; MORPHINE; PAIN; TREATMENT OUTCOME;

EID: 34247550664     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/sj.jp.7211712     Document Type: Article

References (55)

1. Merskey H. The definition of pain. Eur J Psychiatry 1991; 6: 153–159.
2. Anand KJS, Craig KD. New perspectives on the definition of pain. Pain 1996; 67: 3–6.
3. Malviya S, Voepel-Lewis T, Tait AR, Merkel S, Lauer A, Munro H et al. Pain management in children with and without cognitive impairment following spine fusion surgery. Paediatr Anaesth 2001; 11: 453–458.
4. Anand KJS. Clinical importance of pain and stress in preterm neonates. Biol Neonate 1998; 73: 1–9.
5. Narsinghani U, Anand KJS. Developmental neurobiology of pain in neonatal rats. Lab Anim 2000; 29: 27–39.
6. Wiesenfeld-Hallin Z. Combined opioid-NMDA antagonist therapies. What advantage do they offer for the control of pain syndromes? Drugs 1998; 55: 1–4.
7. Ruda MA, Ling Q-D, Hohmann AG, Peng YB, Tachibana T. Altered nociceptive neuronal circuits after neonatal peripheral inflammation. Science 2000; 289(5479): 628–631.
8. Anand KJS. Pain, plasticity, and premature birth: A prescription for permanent suffering? Nat Med 2000; 6: 971–973.
9. Anand KJS, Grunau RE, Oberlander T. Developmental character and longterm consequences of pain in infants and children. Child Adolesc Psychiatr Clin N Am 1997; 6: 703–724.
10. Peters JW, Schouw R, Anand KJS, van Dijk M, Duivenvoorden HJ, Tibboel D. Does neonatal surgery lead to increased pain sensitivity in later childhood? Pain 2005; 114: 444–454.
11. Johnston CC, Stevens BJ. Experience in a neonatal intensive care unit affect pain response. Pediatrics 1996; 98: 925–930.
12. Grunau RE, Oberlander TF, Whitfield MF, Fitzgerald C, Lee SK. Demographic and therapeutic determinant of pain reactivity in very low birth neonates at weeks’ postconceptional age. Pediatrics 2001; 107: 105–112.
13. Fitzgerald M, Shaw A, MacIntosh N. The postnatal development of the cutaneous flexor reflex: A comparative study in premature infants and newborn rat pups. Dev Med Child Neurol 1988; 30: 520–526.
14. Fitzgerald M, Millard C, MacIntosh N. Hyperalgesia in premature infants. Lancet 1988; 1(8580): 292.
15. Fitzgerald M, Millard C, McIntosh N. Cutaneous hypersensitivity following peripheral tissue damage in newborn infants and its reversal with topical anaesthesia. Pain 1989; 39: 31–36.
16. Andrews K, Fitzgerald M. The cutaneous withdrawal reflex in human neonates: Sensitization, receptive fields, and the effects of contralateral stimulation. Pain 1994; 56: 95–101.
17. Fitzgerald M, Koltzenburg M. The functional development of descending inhibitory pathways in the dorsolateral funiculus of the newborn rat spinal cord. Brain Res 1986; 389: 261–270.
18. Ren K, Blass EM, Zhou Q, Dubner R. Suckling and sucrose ingestion suppress persistent hyperalgesia and spinal Fos expression after forepaw inflammation in infant rats. Proc Natl Acad Sci 1997; 94: 1471–1475.
19. Fitzgerald M. The development of nociceptive circuits. Nat Rev Neurosci 2005; 6: 507–520.
20. Bartocci M, Bergqvist LL, Lagercrantz H, Anand KJS. Pain activates cortical areas in the preterm newborn brain. Pain 2006; 122: 109–117.
21. Barker DP, Rutter N. Exposure to invasive procedures in neonatal intensive care unit admissions. Arch Dis Child 1995; 72: F47–F48.
22. Porter FL, Anand KJS. Epidemiology of pain in neonates. Res Clin Forums 1998; 20: 9–16.
23. Simons SHP, van Dijk M, Anand KJS, Roofthooft D, van Lingen RA, Tibboel D. Do we still hurt newborn babies? A prospective study of procedural pain and analgesia in neonates. Arch Pediatr Adolesc Med 2003; 157: 1058–1064.
24. Taylor BJ, Robbins JM, Gold JI, Logsdon TR, Bird TM, Anand KJS. Assessing postoperative pain in neonates: A multi-center observational study. Pediatrics 2006; 118: 992–1000.
25. Chambers CT, Ewis GJ, McGrath PJ, Finley GA. Development and preliminary validation of a postoperative pain measure for parents. Pain 1996; 68: 307–313.
26. Tadio A, Lee C, Yip A, Parvez B, McNamara PJ, Shah V. Intravenous morphine and topical tetracaine for treatment of pain in preterm neonates undergoing central line placement. JAMA 2006; 295: 793–800.
27. Young TE, Mangum B (eds.). Neofaxs. 19th edition. Raleigh: Acorn Publishing, 2006, 150–167.
28. Taketomo CK, Hodding JH, Kraus DM (eds.). Pediatric Dosage Handbook. 12th edition. Hudson: Lexi-Comp Inc. 2005.
29. Hardman JG, Limbird LE (eds) Goodman and Gilman’s The Pharmacological Basis of Therapeuticsth edition. McGaw Hill: New York, 2001.
30. Johnston CC, Collinge JM, Henderson SJ, Anand KJS. A cross-sectional survey of pain and pharmacological analgesia in Canadian neonatal intensive care units. Clin J Pain 1997; 13: 308–312.
31. Kahn DJ, Richardson DK, Gray JE, Bednarek F, Rubin LP, Shah B et al. Variation among neonatal intensive care units in narcotic administration. Arch Pediatr Adolesc Med 1998; 152: 844–851.
32. Chay PCW, Duffy BJ, Walker JS. Pharmacokinetic-pharmacodynamic relationships of morphine in neonates. Clin Pharmacol Ther 1992; 51: 334–342.
33. Farrington EA, McGuinness GA, Johnson GF, Erenberg A, Leff RD. Continuous intravenous morphine infusion in postoperative newborn infants. Am J Perinatol 1993; 10: 84–87.
34. Saarenmaa E, Neuvonen PJ, Rosenberg P, Fellman V. Morphine clearance and effects in newborn infants in relation to gestational age. Clin Pharmacol Ther 2000; 68: 160–166.
35. Scott CS, Riggs KW, Ling EW, Fitzgerald CE, Hill ML, Grunau RV et al. Morphine pharmacokinetics and pain assessment in premature newborns. J Pediatr 1999; 135: 423–429.
36. Bouwmeester NJ, Anderson BJ, Tibboel D, Holford NH. Developmental pharmacokinetics of morphine and its metabolites in neonates, infants and young children. Br J Anaesth 2004; 92: 208–217.
37. Selley DE, Sim LJ, Xiao R, Liu Q, Childers SR. mu-Opioid receptor-stimulated guanosine-50-O-(gamma-thio)-triphosphate binding in rat thalamus and cultured cell lines: Signal transduction mechanisms underlying agonist efficacy. Mol Pharmacol 1997; 51: 87–96.
38. Saarenmaa E, Huttunen P, Leppaluoto J, Meretoja O, Fellman V. Advantage of fentanyl over morphine in analgesia for ventilated newborn infants after birth: A randomized trial. J Pediatr 1999; 134: 144–150.
39. Bhat R, Abu-Harb M, Charl G, Gulati A. Morpine metabolism in acutely ill preterm newborn infants. J Pediatr 1992; 120: 795–799.
40. Franck LS, Vilardi J, Durand D, Powers R. Opioid withdrawal in neonates after continuous infusions of morphine or fentanyl during extracorporeal membrane oxygenation. Am J Crit Care 1998; 7: 364–369.
41. Franck LS, Boyce WT, Gregory GA, Jemerin J, Levine J, Miaskowski C. Plasma norepinephrine levels, vagal tone index, and flexor reflex threshold in premature neonates receiving intravenous morphine during the postoperative period: A pilot study. Clin J Pain 2000; 16: 95–104.
42. Simons SHP, van Dijk M, van Lingen RA, Roofthooft D, Duivenvoorden HJ, Jongeneel N et al. Routine morphine infusion in preterm newborns who received ventilatory support: A randomized controlled trial. JAMA 2003; 290: 2419–2427.
43. Liu JG, Rovnaghi CR, Garg S, Anand KJS. Opioid receptor desensitization contributes to thermal hyperalgesia in infant rats. Eur J Pharmacol 2004; 491: 127–136.
44. Anand KJS, Suresh S. Opioid tolerance in neonates: A state-of-the-art review. Paediatr Anaesth 2001; 11: 511–521.
45. Angeles DM, Wycliffe N, Michelson D, Holshouser BA, Deming DD, Pearce WJ et al. Use of opioids in asphyxiated term neonates: Effects on neuroimaging and clinical outcome. Pediatr Res 2005; 57: 873–878.
46. Anand KJ, Hall RW, Desai N, Shephard B, Bergqvist LL, Young TE et al. Effects of morphine analgesia in ventilated preterm neonates: Primary outcomes from the NEOPAIN randomised trial. Lancet 2004; 363: 1673–1682.
47. Taketomo CK, Hodding JH, Kraus DM (eds). Pediatric dosage handbook. 11th edn. LexiComp: Hudson, Ohio, 2004.
48. Koehntop DE, Rodman JH, Brundage DM, Hegland MG, Buckley JJ. Pharmacokinetics of fentanyl in neonates. Anesth Analg 1986; 65: 227–232.
49. Liu JG, Anand KJS. Protein kinases modulate the cellular adaptations associated with opioid tolerance and dependence. Brain Res Brain Res Rev 2001; 38: 1–19.
50. Chana SK, Anand KJS. Can we use methadone for analgesia in neonates? Arch Dis Child Fetal Neonatal Ed 2001; 85: F79–F81.
51. Wang HY, Friedman E, Olmstead MC, Burns LH. Ultra-low dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor-G protein coupling and Gbg signaling. Neuroscience 2005; 135: 247–261.
52. Green SM, Denmark TK, Cline J, Roghair C, Abd Allah S, Rothrock SG. Ketamine sedation for pediatric critical care procedures. Pediatr Emerg Care. 2001; 17: 244–248.
53. Ikonomidou C, Bosch F, Miksa M, Bittigau P, Vockler J, Dikranian K et al. Blockade of NMDA receptors and apoptic neurodegeneration in the developing brain. Science 1999; 283: 70–74.
54. Soriano SG, Anand KJS, Rovnaghi CR, Hickey PR. Of mice and men: Should we extrapolate rodent experimental data to the care of human neonates? Anesthesiology 2005; 102(4): 866–869.
55. van Alfen der Velden AAEM, Hopman JCW, Klaessens JHGM, Feuth T, Sengers RCA, Liem KD. Effects of midazolam and morphine on cerebral oxygenation and hemodynamics in ventilated premature infants. Biol Neonate 2006; 90: 197–202.